Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial
Gary Wittert(South Australian Health and Medical Research Institute), Karen Bracken(The University of Sydney), Kristy Robledo(The University of Sydney), Mathis Grossmann(The University of Melbourne), Bu B. Yeap(The University of Western Australia), David J. Handelsman(The University of Sydney), Bronwyn Stuckey(Keogh Institute for Medical Research), Ann J. Conway(Anzac Research Institute), Warrick J. Inder(Princess Alexandra Hospital), Robert I. McLachlan(Hudson Institute of Medical Research), Carolyn A Allan(Monash University), David Jesudason(Queen Elizabeth Hospital), Mark Ng Tang Fui(Austin Health), Wendy Hague(The University of Sydney), Alicia J. Jenkins(National Health and Medical Research Council), Mark Daniel(The University of Melbourne), Val Gebski(The University of Sydney), Anthony Keech(National Health and Medical Research Council)
Cited by 344
Abstract
Related Papers
No related papers found
Powered by citation graph analysis